Vincristine
About
Therapy type: Chemotherapy
Therapy strategy: Vinca alkaloid chemotherapy
Mappings
NCI Thesaurus: Vincristine (coding:ncit:C933)
RxNorm: vincristine (coding:rxcui:11202, coding:omop:1308290)
SNOMED: Vincristine (coding:sctid:387126006, coding:omop:4304296)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | BCR::ABL1 | Acute Lymphoid Leukemia | Cytarabine, Dexamethasone, Methotrexate, Ponatinib, Prednisone, Vincristine | |
| FDA (1) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Prednisolone, Rituximab, Vincristine | |
| FDA (1) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine | |
| FDA (2) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine | |
| FDA (1) HC (1) | CD20 + | Diffuse Large B-Cell Lymphoma | Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine | |
| FDA (1) | CD20 + | Burkitt Lymphoma | Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine | |
| FDA (1) | CD20 + | Mature B-Cell Neoplasms | Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine | |
| HC (1) | CD20 + | Diffuse Large B-Cell Lymphoma | Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine | |
| HC (1) | CD20 + | Follicular Lymphoma | Cyclophosphamide, Prednisolone, Rituximab, Vincristine |